|
|
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
Item 2.02
|
Results of Operations and Financial Condition.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Press release issued by AVROBIO, Inc., dated November 8, 2022.
|
|
104
|
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
|
AVROBIO, INC.
|
||
Date: November 8, 2022
|
By:
|
/s/ Geoff MacKay
|
Geoff MacKay
|
||
President and Chief Executive Officer
|